YB-800D

N/A

Report date: 2025/05/19 14:25:57

First In Class

Base Information

Drug NameYB-800D

Drug Alias NameYB-800D

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsNeuronal pentraxin receptor inhibitors

TargetsNeuronal pentraxin receptor

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesYmmunobio AG

China Registration ClassN/A

Active CompaniesYmmunobio AG

Inactive CompaniesN/A

Active IndicationsGastrointestinal Neoplasms

Inactive IndicationsN/A

ATC CodeN/A